Fundraising FoxK2 HealthVentures — 2020 Investments
3 investments dated 2020 · listed companies and verified rows first · show all
Neumora is a clinical research company developing investigational medications, with a focus on conducting clinical trials to obtain regulatory approval and make treatments available to patients.
BiotechDeep TechDigital HealthMedical DevicesWatertown, US
Paul L. Berns(Chairman and Chief Executive Officer)Joshua Pinto(Executive Officer)Tamara Tompkins(Executive Officer)inKari Stefansson(Director)Maykin Ho(Director)Alaa Halawa(Director)
Co-investorsARCH Venture PartnersCatalio Capital Management, LPF-Prime CapitalMercury FundPremier PartnersSoftBank Vision Fund+12 more
BiotechSan Diego, US
Sean Thomas Saint(Executive Officer, Director)Kenneth H. Sunshine(Executive Officer, Director)inMichael Robert Mensinger(Director)
Werewolf Therapeutics is a biotechnology company developing immunotherapy treatments for cancer.
BiotechHealthtechMedical DevicesWatertown, US
Daniel J. Hicklin(Founder, President, Chief Executive Officer, and Board member)Luke Evnin(Co-founder, Board member (Chairman))inDavid Cordo(Executive Officer)Alon Lazarus(Director)
BoardChristoph Westphal(Director)Briggs Morrison(Director)in
Co-investorsDC Investment PartnersLongwood FundMPM BioImpactRA CapitalTaiho Ventures, LLC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.